Stay updated on ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6. This indicates a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-08-30T21:41:13.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's revision number.
    Difference
    0.1%
    Check dated 2026-08-09T08:53:42.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.4, indicating a minor update to the ClinicalTrials.gov record. No study data or criteria appear to be altered.
    Difference
    0.1%
    Check dated 2026-07-25T18:15:34.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study's recruitment status was updated to 'Active, not recruiting' with a note that no participants are being sought, indicating enrollment has closed. Several investigator and contact details were removed, reducing publicly listed study contacts.
    Difference
    4%
    Check dated 2026-07-11T14:29:21.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a new version of the page or its underlying system. This update does not alter the study details or other content presented.
    Difference
    0.0%
    Check dated 2026-07-04T08:21:06.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.2 was added and the previous v3.6.0 tag removed, indicating a minor update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-27T05:59:28.000Z thumbnail image

Stay in the know with updates to ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADT and Pembrolizumab in AR-positive Salivary Gland Carcinoma Clinical Trial page.